BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30463626)

  • 1. Risk of sepsis in patients with primary aldosteronism.
    Chan CK; Hu YH; Chen L; Chang CC; Lin YF; Lai TS; Huang KH; Lin YH; Wu VC; Wu KD;
    Crit Care; 2018 Nov; 22(1):313. PubMed ID: 30463626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of new-onset autoimmune diseases in primary aldosteronism: a nation-wide population-based study.
    Er LK; Chen L; Tsai YC; Lin YH; Huang WC; Chang CC; Lu CC; Huang KH; Chueh JS; Wu KD; Wu VC;
    J Hypertens; 2020 Apr; 38(4):745-754. PubMed ID: 31764584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Fracture in Primary Aldosteronism: A Population-Based Cohort Study.
    Wu VC; Chang CH; Wang CY; Lin YH; Kao TW; Lin PC; Chu TS; Chang YS; Chen L; Wu KD; Chueh SJ
    J Bone Miner Res; 2017 Apr; 32(4):743-752. PubMed ID: 27862274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of new-onset diabetes mellitus in primary aldosteronism: a population study over 5 years.
    Wu VC; Chueh SJ; Chen L; Chang CH; Hu YH; Lin YH; Wu KD; Yang WS;
    J Hypertens; 2017 Aug; 35(8):1698-1708. PubMed ID: 28661412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgery decreases the long-term incident stroke risk in patients with primary aldosteronism.
    Chang YH; Chung SD; Wu CH; Chueh JS; Chen L; Lin PC; Lin YH; Huang KH; Wu VC; Chu TS;
    Surgery; 2020 Feb; 167(2):367-377. PubMed ID: 31676114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenalectomy Improves the Long-Term Risk of End-Stage Renal Disease and Mortality of Primary Aldosteronism.
    Chen YY; Lin YH; Huang WC; Chueh E; Chen L; Yang SY; Lin PC; Lin LY; Lin YH; Wu VC; Chu TS; Wu KD
    J Endocr Soc; 2019 Jun; 3(6):1110-1126. PubMed ID: 31086833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Different Treatment Strategies on New-Onset Atrial Fibrillation Among Patients With Primary Aldosteronism: A Nationwide Longitudinal Cohort-Based Study.
    Pan CT; Liao CW; Tsai CH; Chen ZW; Chen L; Hung CS; Liu YC; Lin PC; Chang CC; Chang YY; Wu VC; Lin YH;
    J Am Heart Assoc; 2020 Mar; 9(5):e013699. PubMed ID: 32070205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism.
    Somlóová Z; Widimský J; Rosa J; Wichterle D; Strauch B; Petrák O; Zelinka T; Vlková J; Masek M; Dvoráková J; Holaj R
    J Hum Hypertens; 2010 Oct; 24(10):625-30. PubMed ID: 20574447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term outcome of Aldosteronism after target treatments.
    Wu VC; Wang SM; Chang CH; Hu YH; Lin LY; Lin YH; Chueh SC; Chen L; Wu KD
    Sci Rep; 2016 Sep; 6():32103. PubMed ID: 27586402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of visceral adiposity and clinical outcome among patients with aldosterone producing adenoma.
    Er LK; Lin MC; Tsai YC; Hsiao JK; Yang CY; Chang CC; Peng KY; Chueh JS; Wu VC;
    BMJ Open Diabetes Res Care; 2020 Jul; 8(1):. PubMed ID: 32713841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of dementia in primary aldosteronism compared with essential hypertension: a nationwide cohort study.
    Hong N; Kim KJ; Yu MH; Jeong SH; Lee S; Lim JS; Rhee Y
    Alzheimers Res Ther; 2023 Aug; 15(1):136. PubMed ID: 37568223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Abdominal Computed Tomography Scans for Differentiating the Discrepancies in Abdominal Adipose Tissue Between Two Major Subtypes of Primary Aldosteronism.
    Chen KM; Lee BC; Chen PT; Liu KL; Lin KH; Chang CC; Wu TH; Hong JS; Lin YH
    Front Endocrinol (Lausanne); 2021; 12():647184. PubMed ID: 34335463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary aldosteronism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment.
    Turchi F; Ronconi V; di Tizio V; Ceccoli L; Boscaro M; Giacchetti G
    Nutr Metab Cardiovasc Dis; 2014 May; 24(5):476-82. PubMed ID: 24630976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term mortality and cardiovascular events in patients with unilateral primary aldosteronism after targeted treatments.
    Wu VC; Wang SM; Huang KH; Tsai YC; Chan CK; Yang SY; Lin LY; Chang CC; Lu CC; Lin YH; Chen YM; Chueh JS
    Eur J Endocrinol; 2021 Dec; 186(2):195-205. PubMed ID: 34851859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma.
    Lin YH; Lin LY; Chen A; Wu XM; Lee JK; Su TC; Wu VC; Chueh SC; Lin WC; Lo MT; Wang PC; Ho YL; Wu KD;
    Atherosclerosis; 2012 Mar; 221(1):154-9. PubMed ID: 22197109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The application of captopril challenge test in the diagnosis of primary aldosteronism].
    Chen S; Zeng ZP; Song AL; Zhu L; Lu L; Tong AL; Shi C; Li HZ
    Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):402-408. PubMed ID: 28592038
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of biomarkers of endothelial dysfunction and microvascular endothelial function in patients with primary aldosteronism and essential hypertension.
    Sang M; Fu Y; Wei C; Yang J; Qiu X; Ma J; Qin C; Wu F; Zhou X; Yang T; Sun M
    J Renin Angiotensin Aldosterone Syst; 2021; 22(1):1470320321999491. PubMed ID: 33678006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of exercise-induced myocardial ischemia in patients with primary aldosteronism: the Cross-sectional Primary Aldosteronism and Heart Italian Multicenter Study.
    Napoli C; Di Gregorio F; Leccese M; Abete P; Ambrosio G; Giusti R; Casini A; Ferrara N; De Matteis C; Sibilio G; Donzelli R; Montemarano A; Mazzeo C; Rengo F; Mansi L; Liguori A
    J Investig Med; 1999 May; 47(5):212-21. PubMed ID: 10361380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial progenitor cells in primary aldosteronism: a biomarker of severity for aldosterone vasculopathy and prognosis.
    Wu VC; Lo SC; Chen YL; Huang PH; Tsai CT; Liang CJ; Kuo CC; Kuo YS; Lee BC; Wu EL; Lin YH; Sun YY; Lin SL; Chen JW; Lin SJ; Wu KD;
    J Clin Endocrinol Metab; 2011 Oct; 96(10):3175-83. PubMed ID: 21816781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verification and evaluation of aldosteronism demographics in the Taiwan Primary Aldosteronism Investigation Group (TAIPAI Group).
    Kuo CC; Wu VC; Huang KH; Wang SM; Chang CC; Lu CC; Yang WS; Tsai CW; Lai CF; Lee TY; Lin WC; Wu MS; Lin YH; Chu TS; Lin CY; Chang HW; Wang WJ; Kao TW; Chueh SC; Wu KD; Taipai Study Group
    J Renin Angiotensin Aldosterone Syst; 2011 Sep; 12(3):348-57. PubMed ID: 21393359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.